Navigation Links
Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
Date:2/20/2008

ensey Nash has additional improvements underway for the Safe-Cross product line, which will require separate regulatory clearances. Kensey Nash is now finalizing a completely new user interface, designed to simplify the presentation of information important to the physician user. The new user interface, as well as other minor software enhancements, are planned to be introduced in Kensey Nash's fiscal 2009 year.

The Safe-Cross(R) RF CTO System

The Safe-Cross System is designed to safely cross CTOs using Optical Coherence Reflectometry (OCR) technology as guidance and Radio Frequency (RF) as an energy source to penetrate the difficult lesions. The Safe-Cross(R) System is the only commercialized product that combines forward guidance with a crossing mechanism in a familiar guidewire configuration. The System is designed to give the interventionalist real-time feedback as to the proximity of the crossing wire to the arterial wall plus the capability to use RF power on the tip of the wire to assist in penetrating hardened material within the artery, thus facilitating safe and successful passage and placement of therapeutic devices for recanalization in native coronary and peripheral arteries.

This guidance technology is based on optical coherence reflectometry, with near infrared light being transmitted and received through a small optical fiber incorporated into the guidewire. This near infrared signal is analyzed through an interferometer to resolve the reflections by distance, a process analogous to that of ultrasound, but with light rather than acoustic waves. If the vessel wall is detected, RF energy cannot be released and the operator is visually warned of the guidewire's proximity to the wall. The operator can then redirect the guidewire to remain in the lumen and continue its progress through the occlusion. The Safe-Cross System only allows RF energy to be released when the guidewire is directed safely within the lumen of the vessel.

T
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
2. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
3. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
4. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
5. Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
6. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
7. Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
8. BioSpace.com Receives WEDDLEs 2008 Users Choice Award for Best Job Boards
9. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
10. AGA Medical Corporation Receives European CE Mark Approval for the AMPLATZER(R) Duct Occluder II
11. CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... and TEL AVIV, Israel , May ... the "Company") (NYSE MKT: NSPR), a leader in embolic protection ... Company,s President and Chief Executive Officer, and Craig ... in the Benchmark Company, LLC One-on-One Investor Conference on Thursday ... Ave., Milwaukee, WI. The ...
(Date:5/24/2013)... 24, 2013 Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... , Ph.D., the Company,s Vice President, Biology and ... & Corporate Communications, will present an overview of Senomyx,s ... a.m. Eastern Time (7:25 a.m. Pacific Time) during the ...
(Date:5/24/2013)... 2013 This market report summarizes ... profiling carried out in May 2013. The full ... of the responses for each question, its segmentation ... also highlights some interesting differences, particularly between Pharma, ... models were developed to estimate the in house ...
(Date:5/24/2013)... 24, 2013 Many factors impact tissues ... or efflux transporters at the blood-tissue barrier. Even when ... unbound fractions in the tissue rather than the total ... challenges is required to guide lead optimization, predict in ... species-dependent variables that may impact the likely human clinical ...
Breaking Biology Technology:InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2
... Md., Sept. 24 PharmAthene, Inc.,(Amex: ... the development and,commercialization of medical countermeasures against ... of Health and Human,Services has published an ... the,amount of $13,920,347, listing PharmAthene as the ...
... and OXFORD, England, September 24, Evotec AG (Frankfurt Stock ... and Dr John Kemp, Chief,Research & Development Officer, will ... 03.30 pm EST (09.30 pm CET/08.30 pm BST) on,Wednesday, ... During the,presentation management will provide an overview of its ...
... leading,provider of quality research reagents for monitoring the immune ... of its new,MHC-peptide binding assay for Class II HLA ... I HLA already available from the Company. The ... is a,powerful cell-free in vitro assay that can rapidly ...
Cached Biology Technology:Evotec to Present at the UBS 2007 Global Life Sciences Conference in New York 2ProImmune Launches New MHC-Peptide Binding Assay for Class II HLA Alleles 2
(Date:5/24/2013)... system to combat metastatic cancer , Cancer cells ... the immune system. Stimulation of the immune system can ... factors that cause the immune system to ignore cancer ... to suppress the immune system response. In this issue ... led by Ronald Levy at Stanford University found that ...
(Date:5/24/2013)... detection and destruction by the immune system. Stimulation of ... however, there are many factors that cause the immune ... immune cells that function to suppress the immune system ... Clinical Investigation , researchers led by Ronald Levy at ... tumors express proteins that can be targeted with therapeutic ...
(Date:5/24/2013)... recent years, microRNAs (miRNAs) and other non-coding RNAs ... of specific proteins. In recent years they have ... used to establish tissue origin for cancers of ... and screen for disease, but clinically tractable, diagnostic ... are not currently available. In this issue of ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8
... 2012 Commonly prescribed anti-depressants appear to be doing patients ... paper examining the impact of the medications on the entire ... widespread use of these drugs," says Paul Andrews, an evolutionary ... published today in the online journal Frontiers in Psychology ...
... to the antidepressant Zoloft in yeast cells that could ... about how antidepressants work, as well as support the ... neurotransmitter serotonin. In findings published in the journal ... of Ethan Perlstein, an associate research scholar in Princeton,s ...
... the analysis of flavanols in cocoa has been developed ... scientific division of Mars, Incorporated, and recently published in ... the research team,s expertise in flavanol chemistry and analytics, ... of flavanols found in cocoa and chocolate products. Foods ...
Cached Biology News:Evidence shows that anti-depressants likely do more harm than good, researchers find 2Yeast cell reaction to Zoloft suggests alternative cause, drug target for depression 2Yeast cell reaction to Zoloft suggests alternative cause, drug target for depression 3Yeast cell reaction to Zoloft suggests alternative cause, drug target for depression 4Scientists advance field of research with publication of newly validated method for analyzing flavanols in cocoa 2
Rabbit polyclonal to Factor IX ( Abpromise for all tested applications). entrezGeneID: 2158 SwissProtID: P00740...
Adhesion Molecule Antibodies...
Rabbit polyclonal to Glutathione S Transferase alpha ( Abpromise for all tested applications). Antigen: Full length protein: Human Glutathione S Transferase alpha. Entrez GeneID: 2938 Swi...
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
Biology Products: